30.600
+0,66%
2026-10-19
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -38.0% | -21.7% | 0 / 3 | -20.5% | -0.59 pp | -4.14 pp | +11.1% | 0.20 | 8.54 | 889 | −20,5% | 130 | −38,0% | 8.54 | 8.72 | −2,1% |
| Pts | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 30.600 (close price on 2026-10-19)EPS (TTM): 3.584
Financial charts
1.Revenue & growth
VND bn889Q2/26
1.Revenue & growth
VND bn889Q2/26
2.Profit & growth
VND bn130Q2/26
3.Profit mix (Penman)
VND bn695Q2/26
4.Margins & cost structure
%26.2%Q2/26
5.Returns & cash cycle
% · days14.4%Q2/26
6.Earnings quality & cash
VND bn536Q2/26
7.Asset structure
VND bn6.277Q2/26
8.Funding & debt health
VND bn · times6.277Q2/26
9.Revenue backlog
VND bn19,1Q2/26
10.Valuation
times · %8,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %814Q2/26
Adjusted EPS growth, latest quarter
-38.0%
Average adjusted EPS growth, 3 quarters
-21.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26